Advanced search
Publication Cover
Cancer Investigation Volume 35, 2017 - Issue 8
Submit an article Journal homepage
116
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Primary Management of Squamous Cell Carcinoma of the Anal Canal: A 30-year Community Hospital Experience

Mohit S. AgarwalDepartment of Radiation Oncology, Phoebe Putney Memorial Hospital, Albany, Georgia, USA
,
Daniel. A. JonesDepartment of Radiation Oncology, Phoebe Putney Memorial Hospital, Albany, Georgia, USA
,
Charles M. MendenhallDepartment of Radiation Oncology, Phoebe Putney Memorial Hospital, Albany, Georgia, USA
,
Christopher G. MorrisDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USA
,
Andrew JohnsDepartment of Radiation Oncology, Phoebe Putney Memorial Hospital, Albany, Georgia, USA
,
William J. McAfeeDepartment of Radiation Oncology, Phoebe Putney Memorial Hospital, Albany, Georgia, USA
&
William M. MendenhallDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USACorrespondence[email protected]
 show all
Pages 547-551 | Received 16 May 2017, Accepted 16 Jun 2017, Published online: 01 Aug 2017

References

  • Cancer Facts & Figures. 2017. Atlanta: American Cancer Society; 2017. Available from: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2017.html
  • Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997 May;15(5):2040–2049. PubMed PMID: 9164216.
  • Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 1996;348(9034):1049–1054. PubMed PMID: 8874455.
  • Northover J, Glynne-Jones R, Sebag-Montefiore D, James R, Meadows H, Wan S, et al. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer 2010;102(7):1123–1128. PubMed PMID: 20354531. Pubmed Central PMCID: PMC2853094.
  • Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 2013;86(1):27–33. PubMed PMID: 23154075. Pubmed Central PMCID: PMC3619011.
  • American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
  • Nigro ND, Vaitkevicius VK, Considine B, Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974;17(3):354–356. PubMed PMID: 4830803.
  • Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, et al. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 2007;68(3):794–800. PubMed PMID: 17379452.
  • Rabbani AN, Zlotecki RA, Kirwan J, George TJ, Jr., Morris CG, Rout WR, et al. Definitive radiotherapy for squamous cell carcinoma of the anal canal. Am J Clin Oncol 2010;33(1):47–51. PubMed PMID: 19704368.
  • Muirhead R, Partridge M, Hawkins MA. A tumor control probability model for anal squamous cell carcinoma. Radiother Oncol 2015;116(2):192–196. PubMed PMID: 26243680.
  • Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB, 3rd, et al. Long-term update of US GI intergroup RTOG 98–11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol 2012;30(35):4344–4351. PubMed PMID: 23150707. Pubmed Central PMCID: PMC3515768.
  • James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. Lancet Oncol 2013;14(6):516–524. PubMed PMID: 23578724.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.